查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826995

2025年全球脊椎狹窄治療市場報告

Spinal Stenosis Treatment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，脊椎狹窄治療市場穩定成長，預計2024年將達102億美元，2025年將達106.1億美元，複合年成長率為4.1%。預測期內的成長可歸因於退化性脊椎疾病盛行率的上升、全球老年人口的成長、人們對脊椎相關疾病認知的提高、醫療支出和保險覆蓋率的提高，以及對微創外科手術的需求不斷成長。

預計未來幾年脊椎狹窄治療市場將穩定成長，到2029年將達到123.5億美元，複合年成長率為3.9%。預測期內的成長可歸因於脊椎狹窄及相關退化性疾病的盛行率不斷上升、微創外科手術的普及、對非手術治療方案的需求不斷成長、人們對脊椎健康和治療方案的認知不斷提高，以及對疼痛管理和再生療法的日益關注。預測期內的主要趨勢包括植入和器械技術的進步、遠端保健和數位健康解決方案的普及、支持性監管環境和優惠的報銷政策、人工智慧和機器人技術在手術計劃和治療中的整合，以及對個人化治療方法和患者特定解決方案的關注。

脊椎狹窄症的治療涵蓋醫療和外科干預，旨在緩解脊椎狹窄對脊髓和神經造成的壓力。治療方案包括物理治療、疼痛管理、抗發炎藥物、皮質類固醇注射，以及在嚴重病例中採用切除術和脊椎融合手術術等外科手術，以改善活動能力並緩解不適。

脊椎狹窄症的主要治療類型是頸椎管狹窄症和腰椎管狹窄症。頸椎脊椎狹窄症是指頸部椎管狹窄，壓迫脊椎和神經而發生的疾病。治療方法多種多樣，包括藥物治療、物理治療和手術，適用於各種終端用戶，包括醫院、居家醫療、專科診所和其他醫療機構。

2025 年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療保健提供者正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品成本的上漲，其中許多產品的國內替代品有限。這些不斷上漲的成本使醫療保健預算捉襟見肘，導致一些醫療機構推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，造成供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供脊椎狹窄治療市場統計數據，例如全球市場規模、區域佔有率、脊椎狹窄治療市場佔有率的競爭對手、詳細的脊椎狹窄治療細分市場、市場趨勢以及脊椎狹窄治療行業的商機。這份脊椎狹窄治療市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整展望。

未來五年3.9%的成長預測較先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致比利時和瑞典開發的硬膜外類固醇注射套件和可生物分解脊椎移植的價格上漲，從而延長保守治療週期並增加介入性疼痛管理的成本，從而阻礙美國患者的治療效果。互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響也將產生更廣泛的影響。

脊椎疾病盛行率的不斷上升預計將推動脊椎狹窄治療市場的成長。脊椎疾病包括影響脊椎骨骼、椎間盤、神經和軟組織的疾病，會導致疼痛、活動受限和神經系統症狀。人口老化、久坐不動的生活方式、肥胖、不良姿勢、職業危害和診斷能力的提高等因素導致這些疾病的發病率上升。脊椎狹窄治療旨在緩解神經壓迫、減輕疼痛並增加退化性椎間盤疾病和椎間盤突出等疾病中的活動能力。例如，2023 年 5 月，美國醫療設備公司 Spinal Cord, Inc. 報告稱，美國每年約有 18,000 例新的脊髓損傷 (SCI) 病例，估計全國目前有 302,000 人患有 SCI。因此，脊椎疾病盛行率的不斷上升正在刺激脊椎狹窄治療市場的擴張。

脊椎狹窄治療市場的主要企業正專注於技術進步，例如微創手術 (MIS)植入，以改善手術選擇、提高患者預後並縮短恢復時間。 MIS植入是設計用於使用微創技術植入的醫療設備，與傳統開放性手術相比，它可減少創傷、恢復時間和併發症。例如，2022 年 7 月，美國醫療設備公司 Aurora Spine 獲得了美國食品藥物管理局(FDA) 的擴大批准，可用於其用於治療腰椎脊椎狹窄的 ZIP MIS植入。脊椎管狹窄是一種以脊椎狹窄為特徵的疾病，會導致下背部和腿部疼痛。先前，該植入已被核准用於治療退化性椎間盤疾病、椎間滑脫、創傷和腫瘤。此次擴大核准將使醫生能夠治療更廣泛的患者，並為脊椎狹窄提供更有效的治療方法選擇。

2024年10月，美國醫療保健公司史賽克（Stryker Corporation）收購了Vertos Medical, Inc.，收購金額未揭露。此次收購將增強史賽克針對慢性腰痛的非門診手術治療產品組合，擴大其在門診手術中心的業務，並增強其介入性疼痛管理解決方案。 Vertos Medical是一家美國醫療設備製造商，專注於腰椎脊椎狹窄症的微創治療。

脊椎狹窄治療市場由提供替代療法和整體療法、輔助和支持性護理以及先進和再生療法等服務的營業單位所賺取的收益構成。市場價值還包括服務提供者銷售的或包含在其服務產品中的任何相關商品的價值。脊椎狹窄治療市場還包括藥品、醫療設備和手術器械的銷售。該市場的價值是指“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球脊椎狹窄症治療：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球脊椎狹窄治療市場：成長率分析
  • 全球脊椎狹窄治療市場表現：規模與成長，2019-2024
  • 全球脊椎狹窄治療市場預測：規模與成長，2024-2029年，2034年
  • 全球脊椎狹窄症治療：總目標市場（TAM）

第6章 市場細分

  • 全球脊椎狹窄治療市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 頸椎狹窄
  • 脊椎狹窄症
  • 全球脊椎狹窄症治療市場（依治療、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 藥品
  • 物理治療
  • 外科手術
  • 其他治療方法
  • 全球脊椎狹窄治療市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 居家護理
  • 專科診所
  • 其他最終用戶
  • 全球脊椎狹窄治療市場：依頸椎狹窄類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 物理治療
  • 製藥
  • 脊椎注射
  • 減壓手術
  • 脊椎融合手術
  • 全球脊椎狹窄症治療市場：細分：脊椎狹窄症（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 疼痛管理
  • 硬脊膜外類固醇注射
  • 微創手術
  • 切除術
  • 人工全人工椎間盤置換術

第7章 區域和國家分析

  • 全球脊椎狹窄治療市場：按地區、結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球脊椎狹窄治療市場：按國家、結果和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 脊椎狹窄治療市場：競爭格局
  • 脊椎狹窄治療市場：公司簡介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sumitomo Dainippon Pharma Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Ono Pharmaceutical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Stryker Corporation
  • Globus Medical Inc.
  • Orthofix Holdings Inc.
  • Aesculap Implant Systems LLC
  • Alphatec Spine Inc
  • RTI Surgical Holdings Inc
  • B. Braun Melsungen AG
  • Spinal Elements Inc.
  • Xtant Medical Holdings Inc.
  • Precision Spine Inc.
  • Spineart SA
  • Yungjin Pharm Co. Ltd
  • Zavation Medical Products LLC
  • Aurora Spine Corporation
  • Empirical Spine Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年脊椎狹窄治療市場：提供新機會的國家
  • 2029年脊椎狹窄治療市場：細分領域帶來新機會
  • 2029年脊椎狹窄治療市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r34155u

Spinal stenosis treatment encompasses medical and surgical interventions designed to alleviate pressure on the spinal cord and nerves caused by the narrowing of the spinal canal. Treatment options include physical therapy, pain management, anti-inflammatory medications, corticosteroid injections, and, in severe cases, surgical procedures such as laminectomy or spinal fusion to improve mobility and reduce discomfort.

The primary types of spinal stenosis treatment are cervical stenosis and lumbar stenosis. Cervical stenosis occurs when the spinal canal narrows in the neck region, exerting pressure on the spinal cord and nerves, which may result in pain, numbness, or weakness in the arms and legs. Various treatment approaches, including medication, physical therapy, and surgery, are utilized by different end users, such as hospitals, home care, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The spinal stenosis treatment market research report is one of a series of new reports from The Business Research Company that provides spinal stenosis treatment market statistics, including the spinal stenosis treatment industry global market size, regional shares, competitors with the spinal stenosis treatment market share, detailed spinal stenosis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the spinal stenosis treatment industry. This spinal stenosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The spinal stenosis treatment market size has grown steadily in recent years. It will grow from $10.2 billion in 2024 to $10.61 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to the rising prevalence of degenerative spinal conditions, increasing geriatric population globally, growing awareness of spine-related disorders, increased healthcare spending and insurance coverage, and rising demand for minimally invasive surgical procedures.

The spinal stenosis treatment market size is expected to see steady growth in the next few years. It will grow to $12.35 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to the growing prevalence of spinal stenosis and related degenerative conditions, rising adoption of minimally invasive surgical procedures, growing demand for non-surgical treatment options, rising awareness of spine health and treatment options, and increasing focus on pain management and regenerative therapies. Major trends in the forecast period include advancements in implant and device technology, adoption of telehealth and digital health solutions, a supportive regulatory landscape and favorable reimbursement policies, integration of AI and robotics in surgical planning and treatment, a focus on personalized treatment approaches, and patient-specific solutions.

The forecast of 3.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. patient outcomes by inflating prices of epidural steroid injection kits and biodegradable spinal implants developed in Belgium and Sweden, resulting in prolonged conservative care cycles and higher interventional pain management expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of spinal disorders is expected to drive the growth of the spinal stenosis treatment market. Spinal disorders encompass conditions affecting the spine's bones, discs, nerves, or soft tissues, leading to pain, mobility limitations, or neurological symptoms. Factors such as aging, sedentary lifestyles, obesity, poor posture, occupational hazards, and improved diagnostic capabilities contribute to the rising incidence of these conditions. Spinal stenosis treatments aim to relieve nerve compression, reduce pain, and enhance mobility in disorders such as degenerative disc disease and herniated discs. For example, in May 2023, Spinal Cord, Inc., a US-based medical device company, reported that approximately 18,000 new spinal cord injury (SCI) cases occur annually in the United States, with an estimated 302,000 individuals currently living with SCI nationwide. As a result, the increasing prevalence of spinal disorders is fueling the expansion of the spinal stenosis treatment market.

Leading companies in the spinal stenosis treatment market are focusing on technological advancements, such as minimally invasive surgery (MIS) implants, to improve surgical options, enhance patient outcomes, and shorten recovery times. MIS implants are medical devices designed for implantation using minimally invasive techniques, which reduce trauma, recovery time, and complications compared to traditional open surgery. For instance, in July 2022, Aurora Spine, a US-based medical device company, received expanded U.S. Food and Drug Administration (FDA) clearance for its ZIP MIS implants for lumbar spinal stenosis. This condition, characterized by the narrowing of the spinal canal, causes back and leg pain. Previously, the implants were approved for treating degenerative disc disease, spondylolisthesis, trauma, and tumors. The expanded approval allows physicians to treat a broader range of patients, increasing the availability of effective treatment options for spinal stenosis.

In October 2024, Stryker Corporation, a US-based medical company, acquired Vertos Medical, Inc. for an undisclosed amount. This acquisition strengthens Stryker's portfolio of non-surgical treatments for chronic lower back pain and expands its presence in ambulatory surgery centers, reinforcing its interventional pain management solutions. Vertos Medical, a US-based medical device company, specializes in minimally invasive treatments for lumbar spinal stenosis.

Major players in the spinal stenosis treatment market are Johnson & Johnson, Medtronic plc, Zimmer Biomet Holdings Inc., Sumitomo Dainippon Pharma Co. Ltd, Ono Pharmaceutical Co. Ltd, Stryker Corporation, Globus Medical Inc., Orthofix Holdings Inc., Aesculap Implant Systems LLC, Alphatec Spine Inc, RTI Surgical Holdings Inc, B. Braun Melsungen AG, Spinal Elements Inc., Xtant Medical Holdings Inc., Precision Spine Inc., Spineart SA, Yungjin Pharm Co. Ltd, Zavation Medical Products LLC, Aurora Spine Corporation, and Empirical Spine Inc.

North America was the largest region in the spinal stenosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in spinal stenosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spinal stenosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spinal stenosis treatment market consists of revenues earned by entities by providing services such as alternative and holistic therapies, assistive and supportive care, and advanced and regenerative therapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The spinal stenosis treatment market also includes sales of pharmaceuticals, medical devices, and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spinal Stenosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spinal stenosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spinal stenosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spinal stenosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cervical Stenosis; Lumbar Stenosis
  • 2) By Treatment: Medication; Physical Therapy; Surgery; Other Treatments
  • 3) By End Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Cervical Stenosis: Physical Therapy; Medications; Spinal Injections; Decompression Surgery; Spinal Fusion
  • 2) By Lumbar Stenosis: Pain Management; Epidural Steroid Injections; Minimally Invasive Procedures; Laminectomy; Artificial Disc Replacement
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Zimmer Biomet Holdings Inc.; Sumitomo Dainippon Pharma Co. Ltd; Ono Pharmaceutical Co. Ltd; Stryker Corporation; Globus Medical Inc.; Orthofix Holdings Inc.; Aesculap Implant Systems LLC; Alphatec Spine Inc; RTI Surgical Holdings Inc; B. Braun Melsungen AG; Spinal Elements Inc.; Xtant Medical Holdings Inc.; Precision Spine Inc.; Spineart SA; Yungjin Pharm Co. Ltd; Zavation Medical Products LLC; Aurora Spine Corporation; Empirical Spine Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spinal Stenosis Treatment Market Characteristics

3. Spinal Stenosis Treatment Market Trends And Strategies

4. Spinal Stenosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Spinal Stenosis Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Spinal Stenosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Spinal Stenosis Treatment Market Growth Rate Analysis
  • 5.4. Global Spinal Stenosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Spinal Stenosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Spinal Stenosis Treatment Total Addressable Market (TAM)

6. Spinal Stenosis Treatment Market Segmentation

  • 6.1. Global Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cervical Stenosis
  • Lumbar Stenosis
  • 6.2. Global Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medication
  • Physical Therapy
  • Surgery
  • Other Treatments
  • 6.3. Global Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users
  • 6.4. Global Spinal Stenosis Treatment Market, Sub-Segmentation Of Cervical Stenosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Physical Therapy
  • Medications
  • Spinal Injections
  • Decompression Surgery
  • Spinal Fusion
  • 6.5. Global Spinal Stenosis Treatment Market, Sub-Segmentation Of Lumbar Stenosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Epidural Steroid Injections
  • Minimally Invasive Procedures
  • Laminectomy
  • Artificial Disc Replacement

7. Spinal Stenosis Treatment Market Regional And Country Analysis

  • 7.1. Global Spinal Stenosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Spinal Stenosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Spinal Stenosis Treatment Market

  • 8.1. Asia-Pacific Spinal Stenosis Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Spinal Stenosis Treatment Market

  • 9.1. China Spinal Stenosis Treatment Market Overview
  • 9.2. China Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Spinal Stenosis Treatment Market

  • 10.1. India Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Spinal Stenosis Treatment Market

  • 11.1. Japan Spinal Stenosis Treatment Market Overview
  • 11.2. Japan Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Spinal Stenosis Treatment Market

  • 12.1. Australia Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Spinal Stenosis Treatment Market

  • 13.1. Indonesia Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Spinal Stenosis Treatment Market

  • 14.1. South Korea Spinal Stenosis Treatment Market Overview
  • 14.2. South Korea Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Spinal Stenosis Treatment Market

  • 15.1. Western Europe Spinal Stenosis Treatment Market Overview
  • 15.2. Western Europe Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Spinal Stenosis Treatment Market

  • 16.1. UK Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Spinal Stenosis Treatment Market

  • 17.1. Germany Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Spinal Stenosis Treatment Market

  • 18.1. France Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Spinal Stenosis Treatment Market

  • 19.1. Italy Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Spinal Stenosis Treatment Market

  • 20.1. Spain Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Spinal Stenosis Treatment Market

  • 21.1. Eastern Europe Spinal Stenosis Treatment Market Overview
  • 21.2. Eastern Europe Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Spinal Stenosis Treatment Market

  • 22.1. Russia Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Spinal Stenosis Treatment Market

  • 23.1. North America Spinal Stenosis Treatment Market Overview
  • 23.2. North America Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Spinal Stenosis Treatment Market

  • 24.1. USA Spinal Stenosis Treatment Market Overview
  • 24.2. USA Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Spinal Stenosis Treatment Market

  • 25.1. Canada Spinal Stenosis Treatment Market Overview
  • 25.2. Canada Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Spinal Stenosis Treatment Market

  • 26.1. South America Spinal Stenosis Treatment Market Overview
  • 26.2. South America Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Spinal Stenosis Treatment Market

  • 27.1. Brazil Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Spinal Stenosis Treatment Market

  • 28.1. Middle East Spinal Stenosis Treatment Market Overview
  • 28.2. Middle East Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Spinal Stenosis Treatment Market

  • 29.1. Africa Spinal Stenosis Treatment Market Overview
  • 29.2. Africa Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Spinal Stenosis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Spinal Stenosis Treatment Market Competitive Landscape
  • 30.2. Spinal Stenosis Treatment Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sumitomo Dainippon Pharma Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ono Pharmaceutical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Spinal Stenosis Treatment Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. Globus Medical Inc.
  • 31.3. Orthofix Holdings Inc.
  • 31.4. Aesculap Implant Systems LLC
  • 31.5. Alphatec Spine Inc
  • 31.6. RTI Surgical Holdings Inc
  • 31.7. B. Braun Melsungen AG
  • 31.8. Spinal Elements Inc.
  • 31.9. Xtant Medical Holdings Inc.
  • 31.10. Precision Spine Inc.
  • 31.11. Spineart SA
  • 31.12. Yungjin Pharm Co. Ltd
  • 31.13. Zavation Medical Products LLC
  • 31.14. Aurora Spine Corporation
  • 31.15. Empirical Spine Inc

32. Global Spinal Stenosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spinal Stenosis Treatment Market

34. Recent Developments In The Spinal Stenosis Treatment Market

35. Spinal Stenosis Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Spinal Stenosis Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Spinal Stenosis Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Spinal Stenosis Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer